Weifa ASA : Distribution agreement in Finland for unique pain products
(Thomson Reuters ONE) -
Weifa has signed a 5-year distribution agreement with the Fysioline Group
(Finland). The agreement covers several of Weifa's most recently launched
products within the pain category, and can be extended to include additional
products. Fysioline will sell, market, and distribute the products on an
exclusive basis in the Finnish market under Weifa's brand names. The first
product will be launched towards the end of 2016.
Fysioline is the leading Finnish wellness and fitness company, and is currently
expanding its pharma division. The company has several market-leading brands
within the pain and joint/muscle categories, sold through Pharmacies.
"We are very happy to have signed our first collaboration agreement for the
Finnish market. This represents an important first step in building a Nordic
platform for our established Weifa brands. The first two products represent a
combined annual peak-sales potential (3-5 years from launch) for Weifa in the
high single-digit million range (NOK). As announced in June 2015, we aim to
expand our business in the Nordic region through different types of partnerships
and acquisitions. In December 2015, we acquired Asan and Sana with sales in
Norway and Sweden, and now we have made our first move into Finland", says
Kathrine Gamborg Andreassen (CEO Weifa).
For further information, please contact:
Kathrine Gamborg Andreassen
CEO
+47 95 17 86 80
kathrine.gamborg.andreassen(at)weifa.no
About Weifa: Weifa is Norway's leading Consumer health company. Weifa supplies
pharmaceutical products and lifestyle products that address the essential needs
of consumers, customers and professional partners. The Company has a strong
position in Norway and is the market leader in pain relief, with well-
established brands such as Paracet and Ibux, and is also present in other key
areas such as intimate care, dietary supplements and treatment for colds and
respiratory problems. Weifa is listed on the Oslo Stock Exchange and has its
head office in Oslo. In 2015, the Group had a turnover of approximately NOK
332m (after adjusting for the divestment of the B2B business). The company
currently has approximately 30 employees.
About Fysioline: The Fysioline Group is the leading provider of fitness and
healthcare products and services in Finland. Its chain of fitness and wellness
centers holds a market leading position within the areas of physiotherapy,
rehabilitation and fitness, and the company is also the dominating supplier of
equipment for these sectors. The Pharma division has developed several market
leading brands within the pain and joint/muscle categories, including the
IcePower product range, which is exported to some 50 countries. Fysioline's
range of Medical Devices and drug products is actively marketed to health-care
professionals and consumers around Finland, and is sold exclusively through
Pharmacies. The Group was founded in 1990, and is privately held. Total Group
revenues amounted to some Euro 40 million in 2015.
This information is subject to the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.
This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Weifa ASA via GlobeNewswire
[HUG#2018227]
Unternehmensinformation / Kurzprofil:
Datum: 06.06.2016 - 13:30 Uhr
Sprache: Deutsch
News-ID 475875
Anzahl Zeichen: 3997
contact information:
Town:
Oslo
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 219 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Weifa ASA : Distribution agreement in Finland for unique pain products"
steht unter der journalistisch-redaktionellen Verantwortung von
Weifa ASA (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
